This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder will demonstrate a safe and effective way to manage patients. Results could improve the current protocols for the treatment of individuals with opioid use disorder and severe infections.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
71
Participants will be complete IV antibiotics with OPAT. All participants will receive buprenorphine treatment of OUD.
All participants will receive treatment of OUD and the infection per usual clinical care.
University of Kentucky
Lexington, Kentucky, United States
Illicit Opioid Use
Proportion of urine samples with negative urine drug screen for illicit opioid use
Time frame: 12 weeks after hospital discharge
Completion of Recommended IV Antibiotic Therapy
number of patients who completed recommended IV antibiotic therapy
Time frame: up to 12 weeks (duration of IV antibiotic course as determined by treating physician)
Abstinence From Illicit Opioid
Self-reported number of days of illicit opioid abstinence
Time frame: 12 weeks after hospital discharge
Injection Drug Use
Self-reported number of days of injection use of any drug
Time frame: 12 weeks after hospital discharge
Outpatient Treatment Retention
Number of days patients remain in treatment.
Time frame: 12 weeks after hospital discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.